This grant is for the purpose of continuing the National Cancer Institute’s (NCI) Pediatric Phase 1/Pilot Consortium. This program is essential for conducting Phase 1 and pilot studies in children with cancer, enabling the timely introduction of new agents into pediatric oncology. The Consortium’s rapid ‘first-in-children’ study capability is vital for NCI’s clinical research in childhood cancer. It requires a robust, multi-institutional, multi-disciplinary team adept at designing and executing these trials, within ethical guidelines for children. The ultimate goal is to significantly improve therapy outcomes for children with cancer.
Opportunity ID: 136893
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-12-502 |
| Funding Opportunity Title: | Pediatric Phase 1/Pilot Consortium (Limited Competition UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 05, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 20, 2012 |
| Current Closing Date for Applications: | Mar 20, 2012 |
| Archive Date: | Apr 20, 2012 |
| Estimated Total Program Funding: | $3,470,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: The eligibility to apply in response to this FOA is limited to the current recipient of the Children’s Oncology Group Phase 1/Pilot Consortium award. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding opportunity Announcement (FOA) is to continue the NCIs program for Pediatric Phase 1/Pilot Consortium. The function of the Consortium is to conduct Phase 1 and pilot studies in children with cancer so that new agents can be introduced into the pediatric oncology setting in a timely manner. The Consortium’s ability to quickly conduct first in children studies is critical to NCIs overall clinical research program for children with cancer. To accomplish the objectives of the FOA, a strong multi-institutional, multi-disciplinary research team is needed that can rapidly and efficiently design and conduct Phase 1 and pilot clinical trials and that is experienced in doing so within the ethical constraints applicable to research involving children. The ultimate purpose for supporting the Pediatric Phase 1/Pilot Consortium is to improve therapy outcomes for children with cancer. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-502.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.
Share This Post, Choose Your Platform!
About the Author: osnqt
